The report offers detailed coverage of Closed System Transfer Device (CSTD) industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Closed System Transfer Device (CSTD) by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
Closed System Transfer Device (CSTD) is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
Now some companies see the future profit, they started to expand their investment on Closed System Transfer Device (CSTD) to occupy the market share.For Example, Equashield, a leading provider of Closed System Transfer Devices (CSTDs) for the safe and simple handling of hazardous drugs, today held a groundbreaking for a new manufacturing plant. The company will invest an estimated $30 million to build the new plant to meet the growing market demand for manual and automated hazardous drug compounding devices.
Corvida Medical has leveraged about $6 million in non-dilutive federal, state, and private awards and secured $2.25 million in Series A proceeds to achieve critical milestones to date. Corvida completed a $10.9 million Series B over a series of tranches with the final closing in mid-2015 and is now seeking a convertible note investment, with $3.8 million already committed and on track to close Q1 2016. Management anticipates a $7-10 million Series C late 2016/early 2017 (including the convertible note proceeds) with funds to be used to scale-up manufacturing capacity, build-out production inventory, add personnel, and fuel revenue growth. Corvida has an opportunity to achieve cash flow positive within 2 years of launch (on roughly $1 million in monthly sales), and a realistic opportunity to ramp revenues to $20-30 million within 2-3 years!Meanwhile, the government's attitude has a huge impact on the market. However, now, only the United States and some European and Asia countries have promulgated relevant policies. But, even in these countries, the level of promotion is still relatively low.
USA dominated the Closed System Transfer Device (CSTD), and is the largest production base. In addition to USA, there are some other production areas, such as Europe. In consumption market, North America is the mainly consumption regions due to the bigger demand of downstream applications. In 2017, North America occupied 89.37% of the global consumption value in total. But the above forecast is based on the current policy. If a country suddenly made the relevant policies, then the entire market will change.
The report forecast global Closed System Transfer Device (CSTD) market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global Closed System Transfer Device (CSTD) market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
BD Medical, Inc
Equashield, LLC
ICU Medical, Inc
Teva Medical Ltd
Corvida Medical
At the same time, we classify Closed System Transfer Device (CSTD) according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
Closed Vial Access Devices
Closed Syringe Safety Devices
Closed Bag/Line Access Devices
Market by Application
Hospital
Clinic
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Closed System Transfer Device (CSTD) market for the forecast period 2021 - 2025?
• What are the driving forces in the Closed System Transfer Device (CSTD) market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Closed System Transfer Device (CSTD) industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?